4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Otofarma S.P.A. (OTO) operates in the Medical Devices industry and is headquartered in Naples, Italy. Its market capitalization is roughly €14 million. In the fiscal year ended 2024-12-31, OTO reported €15M in revenue and €1M in net income.
Otofarma S.P.A. engages in construction, production and distribution of custom-made hearing aids. The company provides hearing aid solutions under ENDO, CIC, and retro micro series. It also offer accessories, such as remote control, TV connector, battery charger, charger D, power bank, and remote plus application.
Interactive charts & full statements → Open the OTO valuation workbench →
| Income statement | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total Revenue | €15M | €12M |
| Gross Profit | €14M | €10M |
| Operating Income (EBIT) | €2M | €1M |
| Net Income | €1M | €0M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total Assets | €10M | €8M |
| Total Liabilities | €5M | €5M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OTO viewer.
About TickerBase · Data methodology & sources · Privacy · Terms